OncoC4 Locks in $50 Million Series B to Advance Cancer Drug Pipeline
OncoC4 has secured nearly $50 million in fresh funding, closing its Series B round with GBA Fund at the helm and strong participation from existing backers HM Capital, 3E Bioventures…
